[
    [
        {
            "time": "",
            "original_text": "董事长上任不足3月被刑拘，昔日对手市值已超十倍，CRO领域“理工男”进入多事之秋？ 董监高成员异常事件",
            "features": {
                "keywords": [
                    "董事长",
                    "刑拘",
                    "CRO领域",
                    "理工男",
                    "多事之秋",
                    "董监高成员异常"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "CRO",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "董事长上任不足3月被刑拘，昔日对手市值已超十倍，CRO领域“理工男”进入多事之秋？ 董监高成员异常事件",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "恒瑞医药、爱尔眼科、长春高新等医药白马跌至年线，是机会吗？",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "爱尔眼科",
                    "长春高新",
                    "医药白马",
                    "跌至年线"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "恒瑞医药、爱尔眼科、长春高新等医药白马跌至年线，是机会吗？",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]